Skip to main content

Table 1 Demographic and clinical characteristics of 32 patients infected with CRF65_cpx

From: Natural presence of the V179D and K103R/V179D mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors in HIV-1 CRF65_cpx strains

Accession number Subtype in the database Sex Risk factor Sampling year Geographic origin ART NNRTI resistance mutations
MG706585 CRF65_cpx M MSM 2014 Hebei Treatment naive V179D
KP698506 CRF65_cpx M NA 2011 NA Treatment naive V179D
KT379558 C M MSM 2012 Guangdong Treatment naive V179D
KR823099 C M MSM 2014 Beijing Treatment naive V179D
JQ898223 CRF65_cpx M IDU 2009 Yunnan Treatment experienced V179D, Y181C, H221Y
KR822879 C M MSM 2010 Beijing Treatment naive V179D
MG706490 CRF65_cpx M MSM 2014 Hebei Treatment naive V179D
KP250691 C M MSM 2009 Beijing Treatment naive V179D
MG706508 CRF65_cpx M MSM 2014 Hebei Treatment naive V179D
KP698505 CRF65_cpx M MSM 2010 Beijing Treatment naive V179D
KP698503 CRF65_cpx M MSM 2010 Beijing Treatment naive V179D
KX198586 CRF65_cpx M MSM 2013 Hebei Treatment naive K103R, V179D
KF714341 C F HET 2009 Yunnan Treatment naive V179D
KP698508 CRF65_cpx M MSM 2012 Beijing Treatment naive K103R, V179D
KP698504 CRF65_cpx M MSM 2010 Beijing Treatment naive K103R, V179D
KF714427 C M HET 2011 Yunnan Treatment naive V179D
KR822921 C M MSM 2011 Beijing Treatment naive K103R, V179D
KC183778 CRF65_cpx M MSM 2011 Anhui Treatment naive K103R, V179D
KF714326 C M HET 2009 Yunnan Treatment naive V179D
KP698507 CRF65_cpx M MSM 2012 Beijing Treatment naive V179D
KY713419 C M MSM 2016 Beijing Treatment naive K103R, V179D
KF714479 C F HET 2012 Yunnan Treatment naive V179D
MH051841 CRF65_cpx M MSM 2015 Jilin Treatment naive K103R, V179D
KF714310 C F HET 2009 Yunnan Treatment naive V179D
KF714461 C F HET 2012 Yunnan Treatment naive E138A, V179D
KC870030 CRF65_cpx M HET 2009 Yunnan Treatment naive V179D
KC870027 CRF65_cpx F HET 2010 Yunnan Treatment naive V179D
KF714363 C F HET 2010 Yunnan Treatment naive V179D
MF941253 C NA NA 2014 Heilongjiang Treatment naive K103R, V179E
KT625846 CRF65_cpx NA NA 2013 Yunnan Treatment naive V179D
KC870028 CRF65_cpx F HET 2010 Yunnan Treatment naive V179D
KF714374 BC F HET 2010 Yunnan Treatment naive V179D
  1. ART antiretroviral therapy, M male, F female, HET heterosexual, IDU intravenous drug user, MSM men who have sex with men, NA not available
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us